Berberis baluchistanica
Berberis baluchistanica · Accepted scientific name
Scientific literature: Very Sparse (8 studies) · ★☆☆☆☆
Berberis baluchistanica is a significant medicinal plant known for its diverse therapeutic potential in traditional and modern medicine. Research has highlighted its potent antibacterial, antimicrobial, analgesic, and anticancer activities. Scientific studies focusing on the crude ethanolic root extract and raw powder have demonstrated effectiveness against pathogens such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella typhi. Both the root and leaf portions of the plant serve as valuable sources for these bioactive compounds. Consequently, the plant represents a promising natural resource for developing new pharmacological treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Berberidaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Common Names
Berberis baluchistanica is a distinct species that is widely recognized by its common name, Barberry. This plant belongs to a diverse genus known for its ornamental beauty and hardy nature. Throughout various regions, it is often valued for its unique structural features and vibrant growth patterns. Understanding its common terminology helps gardeners and botanists connect more easily with its specific characteristics. As a result, identifying it as Barberry allows for better integration into diverse landscapes.
Sources: Catalogue of Life (COL)
Taxonomy
Berberis baluchistanica is a fascinating species that belongs to the vast kingdom Plantae. Within this biological realm, it is classified under the class Equisetopsida. It further belongs to the diverse order Ranunculales, which links it to many other significant flowering plants. This specific plant is a member of the Berberidaceae family, showcasing its unique botanical characteristics. Finally, it is firmly rooted in the genus Berberis, which defines its evolutionary lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Berberidaceae |
| Genus | Berberis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Berberis baluchistanica displays a diverse geographic range that spans across several distinct climatic regions. In the Asia-Temperate zone, its presence is noted within the Arabian Peninsula and specifically throughout Oman. Moving into the Asia-Tropical regions, the plant is widely distributed across the Indian Subcontinent. Its habitat also extends significantly into the rugged landscapes of Pakistan. This wide distribution highlights the plant's remarkable ability to adapt to varying environmental conditions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Berberis baluchistanica is a medicinal plant that demonstrates a diverse range of therapeutic properties across its various parts. Research confirms that its extracts possess significant antimicrobial activities, specifically exhibiting both antibacterial and antifungal effects against a broad spectrum of pathogens. Furthermore, the plant has shown notable anticancer potential, particularly when testing the efficacy of its bark and root extracts against specific cell lines. Studies also highlight its traditional and scientific value as an analgesic, providing significant antinociceptive effects in animal models. These combined biological activities establish the plant as a promising candidate for the development of new medicinal compounds.
Compounds
Berberis baluchistanica is a medicinal plant recognized for its diverse array of bioactive compounds. Extensive screening of its root extract has confirmed the presence of important phytochemicals, including anthraquinones and cardiac glycosides. The plant also contains significant amounts of flavonoids, which contribute to its functional potential. Additionally, the chemical profile is enriched with saponins and steroids that support its traditional medicinal uses. These various secondary metabolites collectively underpin the plant's antioxidant and antimicrobial properties.
Conditions
Berberis baluchistanica demonstrates significant antibacterial potential by treating various pathogenic bacteria including Escherichia coli and Klebsiella pneumoniae. The plant extracts also show effectiveness in treating Salmonella typhi and Pseudomonas aeruginosa. Furthermore, the medicinal properties of the plant allow it to treat Staphylococcus aureus, which was identified as a highly sensitive strain. These antibacterial relationships are supported by the presence of diverse phytochemical constituents in the plant's bark, leaves, and roots.
Preparations
Berberis baluchistanica is prepared as a crude ethanolic root extract to evaluate its bioactive, antioxidant, and antimicrobial properties. This plant is also prepared as an extract to investigate its significant antinociceptive and anti-inflammatory effects in animal models. Furthermore, Berberis baluchistanica is prepared as a raw powder for medicinal use. Scientific analysis suggests that an adult's daily safe dose of this raw powder should be approximately 2-5 g/day. These various preparations allow for the assessment of the plant's diverse therapeutic potentials and elemental safety.
Parts used
Berberis baluchistanica is a highly medicinal plant that contains various bioactive components within its different anatomical structures. Research indicates that the root of this species is particularly rich in phytochemicals such as alkaloids, tannins, and flavonoids, which contribute to its significant antimicrobial and antioxidant properties. Similarly, the leaves of the plant exhibit substantial biological potential, including notable antifungal and anti-leishmanial activities. Both the root and leaf extracts have demonstrated the ability to inhibit various pathogens, making them valuable for therapeutic study. Consequently, these specific parts of the plant serve as promising candidates for isolating new anticancer and anti-inflammatory compounds.